Neoadjuvant Nivolumab–Ipilimumab versus Platinum-Based Chemotherapy in Muscle-Invasive Bladder Cancer: A Single-Institution, Propensity-Weighted Cohort Study
Cancer Management and Research · 2026-11 · Volume 18 · 1-13
DOI: 10.2147/cmar.s642002 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cancer Management and Research, 2026-11. Verfasst von Li-Hua Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan.
- Doctoral Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan.
- Rong Hsing Translational Medicine Research Center, National Chung Hsing University, Taichung, Taiwan.
- Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
- Department of Nursing, Jenteh Junior College of Medicine, Nursing and Management, Miaoli, Taiwan.
- Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
ORCID-Profile: Li-Hua Huang
Zitieren
APA
Huang, L. H., Tung, M. C., Weng, W. C., Hsu, C. Y., Ou, Y. C., & Lin, C. C. (2026). Neoadjuvant Nivolumab–Ipilimumab versus Platinum-Based Chemotherapy in Muscle-Invasive Bladder Cancer: A Single-Institution, Propensity-Weighted Cohort Study. Cancer Management and Research, Volume 18, 1-13. https://doi.org/10.2147/cmar.s642002
Vancouver
Huang LH, Tung MC, Weng WC, Hsu CY, Ou YC, Lin CC. Neoadjuvant Nivolumab–Ipilimumab versus Platinum-Based Chemotherapy in Muscle-Invasive Bladder Cancer: A Single-Institution, Propensity-Weighted Cohort Study. Cancer Management and Research. 2026;Volume 18:1-13. doi:10.2147/cmar.s642002
BibTeX
@article{Huang2026,
author = {Huang, Li-Hua and Tung, Min-Che and Weng, Wei-Chun and Hsu, Chao-Yu and Ou, Yen-Chuan and Lin, Chi-Chien},
title = {Neoadjuvant Nivolumab–Ipilimumab versus Platinum-Based Chemotherapy in Muscle-Invasive Bladder Cancer: A Single-Institution, Propensity-Weighted Cohort Study},
journal = {Cancer Management and Research},
year = {2026},
volume = {Volume 18},
pages = {1--13},
doi = {10.2147/cmar.s642002}
}
EUVIMED